Liza Laws

1 week ago | discover-pharma.com | Liza Laws

Symbiosis Pharmaceutical Services, one of the leading Contract Manufacturing Organisation (CMO) specializing in sterile GMP manufacturing of biopharmaceuticals, has been recognized by EcoVadis, a global provider of business sustainability ratings. The company says it has been awarded a Committed Badge through the EcoVadis recognition system for its efforts in carbon reduction and alignment with the Science Based Targets initiative (SBTi).

1 week ago | discover-pharma.com | Liza Laws

Sphere Bio has expanded its distribution network across Asia-Pacific, appointing five new partners to support regional demand for its single-cell analysis platforms. The company, which specialises in picodroplet-based microfluidics, confirmed new partnerships with 1st PhileKorea, South Korea, As One Corporation, Japan, Decode Science, Australia and New Zealand, Everlife Research Instruments, Singapore, and Premas Life Sciences, India and Bangladesh.

1 week ago | discover-pharma.com | Liza Laws

Tive, a supply chain visibility technology company, has unveiled its new real-time tracking device designed specifically for biologics and pharmaceutical shipments. The company says the device aims to improve cold chain logistics by providing comprehensive visibility into shipment conditions, helping to reduce delays, prevent temperature excursions, ensure compliance, and protect product quality from point of origin to point of delivery.

1 week ago | discover-pharma.com | Liza Laws

As regulatory expectations evolve and patient engagement continues to be a focal point in clinical trials, Teckro has unveiled its Patient Data Return feature. It has been designed to provide patients with easier access to their medical reports while giving sponsors enhanced oversight into engagement levels. This latest update allows clinical trial participants to securely log in, view their assigned study documents, and share them with their healthcare providers.

1 week ago | discover-pharma.com | Liza Laws

Telix Pharmaceuticals Limited has announced that it has selected Cardinal Health, Inc. as one of its commercial distributors for Gozellix (kit for the preparation of gallium-68 (68Ga) gozetotide injection), a next-generation PSMA-PET imaging agent for prostate cancer, following recent US Food and Drug Administration (FDA) approval.